Document Detail


A brief review of sympathomimetic bronchodilators and a description of a new selective agent, rimiterol hydrobromide.
MedLine Citation:
PMID:  25467     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The development of beta2-specific sympathomimetic bronchodilators (rimiterol, salbutamol, terbutaline) has made the basic treatment of asthmatic patients more safe and effective. Despite that, the asthmatics should be under careful control and all patients should be taught the correct way to use their bronchodilator aerosols. If a sympathomimetic drug has lost its effectiveness, the patient should be able to have easy contact to the treating physician or outpatient department.
Authors:
A Muittari
Related Documents :
11736747 - Measurement of ige antibodies against purified grass-pollen allergens (phl p 1, 2, 3, 4...
16800907 - Comparison of fixed percentage method and lower confidence limits for defining limits o...
9731017 - Risk of emergency care, hospitalization, and icu stays for acute asthma among recipient...
15448767 - Implementation of the national asthma management guidelines in the emergency department.
17699327 - Progression of renal disease: renoprotective specificity of renin-angiotensin system bl...
14517677 - Phenotypic variation and vulnerability to predation in juvenile bluegill sunfish (lepom...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Respiration; international review of thoracic diseases     Volume:  35     ISSN:  0025-7931     ISO Abbreviation:  Respiration     Publication Date:  1978  
Date Detail:
Created Date:  1978-06-28     Completed Date:  1978-06-28     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0137356     Medline TA:  Respiration     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  173-80     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic beta-Agonists* / pharmacology,  therapeutic use
Aerosols
Animals
Asthma / drug therapy,  mortality
Bronchial Spasm / drug therapy
Bronchodilator Agents* / pharmacology,  therapeutic use
Catechols* / pharmacology
Humans
Piperidines* / pharmacology
Chemical
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Aerosols; 0/Bronchodilator Agents; 0/Catechols; 0/Piperidines; 32953-89-2/rimiterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients.
Next Document:  The effect of dibutyryl cyclic AMP and glucagon on the myocardial cell pH1.